Mitsubishi Tanabe Pharma America
UEI: C9L7DNEYYNR3
• CAGE: 7XE36
Overview
Parent Awardee
Name
Mitsubishi Tanabe Pharma America
Headquarters
Jersey City, NJ
United States
United States
Federal recipient
MITSUBISHI TANABE PHARMA AMERICA, INC.
(UEI C9L7DNEYYNR3, CAGE 7XE36)
is headquartered in Jersey City NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in February 2016 and
federally registered in
July 2017.
Federal Registration and Certifications
Legal Name
MITSUBISHI TANABE PHARMA AMERICA, INC.
UEI
C9L7DNEYYNR3
CAGE Code
7XE36
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 8, 2016
Initial Registration
July 6, 2017
Last Registration
June 16, 2024
Registration Activation
June 16, 2024
Registration Expiration
June 15, 2025
Fiscal Year End
March 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Mitsubishi Tanabe Pharma America
GSA Schedules and Price Lists
- Mitsubishi Tanabe Pharma America
- PoP: 12/31/23 - 12/31/28
- Mitsubishi Tanabe Pharma America
- PoP: 12/14/17 - 12/31/23 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)